| Latvia |
Central office of JSC «Grindeks» is located in the capital of Latvia, Riga, ensuring processes of the concern monitoring, governance and management. Manufacturing units of «Grindeks» active pharmaceutical ingredients, ready-made forms, capsules and syrups is located in Riga.
Read more 
|
| Lithuania |
Representative office of JSC «Grindeks» in Lithuania was created in 1997; affiliate of «Grindeks» was developed in 2005.
Read more
|
| Estonia |
«Grindeks» subsidiary company Tallinn pharmaceutical plant where ointments are produced is located in Estonia.
Read more |
| Belarus |
Representative office of JSC «Grindeks» operates in Byelorussia since January 2002. Main duties of the 9 employees that work in the office is to ensure registration process of «Grindeks» medications in this country, sales and distribution of the products in the local market while securing stable cooperation with the main wholesalers and performing activities for the awareness rising of «Grindeks» brand.
Read more |
| Russia |
Russia is one of the biggest realization markets of «Grindeks» one third of the ready-made medications of «Grindeks» where exported to Russia in 2005. Since 2001 «Grindeks»exports to Russia also active pharmaceutical ingredients (Oxytocine and Droperidol).
Read more |
| Ukraine |
Representative office of JSC «Grindeks» operates in Ukraine since August 2005. Main task of the representative office is to ensure registration process of «Grindeks» products in this country, sales and distribution of medications in the local market while securing stable cooperation with the main wholesalers and performing activities for the awareness rising of «Grindeks» brand.
Read more |
| Moldova |
Representative office of JSC «Grindeks» operates in Moldova since February 2006. Main task of the representative office is to ensure registration process of «Grindeks» products in this country, sales and distribution of medications in the local market while securing stable cooperation with the main wholesalers and performing activities for the awareness rising of «Grindeks» brand.
Read more |
| Poland |
JSC «Grindeks» has entered into agreement of registration and cooperation with the Polish company ELJOT that is authorised to represent interests of «Grindeks»in this country. In Poland ELJOT deals with the registration of «Grindeks» products, marketing and sales as well as solves different issues and uncertainties. Products that are being exported to Poland are ointment Viprosal® and injections of Oxytocine.
Read more |
| Czech Republic |
«Grindeks» has entered into an agreement of registration and cooperation with the company of Czech Republic K+K Pharma that is authorised to represent interests of «Grindeks»in this country. In Czech Republic K+K Pharma deals with the registration, sales and marketing of «Grindeks»products. In Poland «Grindeks» is selling capsules of the brand product Ftorafur®.
Read more |
| Hungary |
«Grindeks» has entered into registration and cooperation agreement with the Hungarian company Medi-Zone,Kft, that is authorised to represent interests of «Grindeks» in this country. In Hungary Medi-Zone,Kft deals with the registration, sales and marketing of «Grindeks» products. In Hungary «Grindeks» is selling capsules of the brand product Ftorafur®.
Read more |
| Finland |
In 2004 JSC «Grindeks»entered into the sales agreement with the Finnish chain of pharmacies Scanpharma, as well as started registration of certain products in Finland - Zopiclone, Paraceptamol, Aspirin, Ibuprofen, Loperamid. Cooperation with Finland is developed since 2004. Active pharmaceutical ingredient Zopiclone is being exported to Finland.
Read more |
| Germany |
JSC «Grindeks»has stable and continuous cooperation with the company Merck Group; its headquarters is located in Germany.
Read more |
| Austria |
JSC «Grindeks» exports and sells active pharmaceutical ingredient Oxytocine to the Austrian market.
Read more |
| Switzerland |
Cooperation of JSC «Grindeks» with Switzerland started since 2001. «Grindeks» is exporting active pharmaceutical ingredients Oxytocine and Droperidol to this country.
Read more |
| Bulgaria |
JSC «Grindeks» has entered into the agreement of registration and cooperation with the Bulgarian company Sopharm about the registration and distribution of «Grindeks» products Mildronate® (kaps in inj) , Ftorafur®, Venlafaksin, Somnol® and Riperoidon.
Since 2001 active pharmaceutical ingredient oxytocine is being exported and sold in Bulgaria.
Read more |
| Belgium |
In 2006 JSC «Grindeks» started cooperation with the Belgium company Pagan. «Grindeks» is exporting active pharmaceutical ingredient Droperidol to this country.
Read more |
| Denmark |
Since 2001 JSC «Grindeks» started active participation in Danish market. «Grindeks» exports active pharmaceutical ingredient Oxytocine to this country. In 2004 «Grindeks» started cooperation with the Danish company Polypeptide Laboratories on the level of selling active pharmaceutical ingredients.
Read more |
| Netherland |
Since 2001 JSC «Grindeks» started cooperation with this country. Company is exporting active pharmaceutical ingredients Oxytocine, Droperidol, Citarabin to this country. In 2005 «Grindeks» started cooperation with the Dutch company Eurovet Animal health about the development of new products (substances) to the veterinary market.
Read more |
| France |
JSC «Grindeks» started cooperation with France in 2001. Company exports active pharmaceutical ingredients – Oxytocine and Droperidol to this country. Along with the selling of active pharmaceutical ingredients «Grindeks» has developed successful cooperation with the company Merck Generiques (part of the Merck Group) in terms of the Research, development and selling of substances to the French market.
Read more |
| Spain |
Since 2001 JSC «Grindeks»exports and sells active pharmaceutical ingredient Oxytocine to Spanish market.
Read more |
| Great Britan |
JSC «Grindeks» started to export substances to Great Britain in 2001; every year export volume is growing.
Read more |
| Ireland |
JSC «Grindeks» started cooperation with Ireland in 2001 by exporting active pharmaceutical ingredient Zopiclone to this country.
Read more |
| Italy |
JSC «Grindeks» exports and sells active pharmaceutical ingredient Oxytocine to the Iltalian market.
Read more |
